Effects of the COVID-19 Pandemic on Fibromyalgia Patients
CompletedNCT04730934
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
In this study, the effects of the symptoms related to the diseases of patients with fibromyalgia during the COVID-19 pandemic, their limitations in their social and business life, the need for different drugs, stress levels and the effect of the pandemic on the disease activity will be evaluated.
Study details
- Official title
- Evaluation of the Physical and Emotional Effects of the COVID-19 Pandemic on Fibromyalgia Patients
- Conditions
- Interventions
- Other: Perceived stress scale
- Other: Fibromyalgia impact questionnaire
- Other: The drugs used before and during the pandemic, the patient's job status, physical activity conditions, pain status
- Sponsor
- Kars State Hospital
- Start date
- 2021-01-01
- Primary completion
- 2021-02-25
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients aged between 18 and 65 years * patients who have low back pain lasting at least 3 months and started before pandemic * patients diagnosed with fibromyalgia for at least 6 months Exclusion Criteria: * patients diagnosed with major depression * patients who have a history of back surgery, fracture, infection, spinal stenosis * patients with malignancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04730934